The story has been corrected to state that InformedDNA is a genetics services firm, not a genetics testing company.

NEW YORK (GenomeWeb) – Genetic services firm InformedDNA today announced it is developing a genetic counseling program as part of a collaboration with Edimer Pharmaceuticals in support of the drug firm's clinical program directed at X-linked hypohidrotic ectodermal dysplasia (XLHED).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.